Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recurrence of hepatocellular carcinoma following liver transplantation
Daniel Hoffman, Neil Mehta
Expert Review of Gastroenterology & Hepatology (2020) Vol. 15, Iss. 1, pp. 91-102
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations
Ashish Kumar, Subrat Kumar Acharya, Shivaram Prasad Singh, et al.
Journal of Clinical and Experimental Hepatology (2023) Vol. 14, Iss. 1, pp. 101269-101269
Closed Access | Times Cited: 26
Postoperative circulating tumor cells predict the benefits of tyrosine kinase inhibitor for hepatocellular carcinoma after transplantation
De‐Zhen Guo, Shi‐Yu Zhang, Man Yang, et al.
Hepatology Research (2025)
Closed Access | Times Cited: 1
The management of post-transplantation recurrence of hepatocellular carcinoma
Luckshi Rajendran, Tommy Ivanics, Marco P. A. W. Claasen, et al.
Clinical and Molecular Hepatology (2021) Vol. 28, Iss. 1, pp. 1-16
Open Access | Times Cited: 53
Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium
Benjamin V. Tran, Demetrios Moris, Daniela Markovic, et al.
Liver Transplantation (2023) Vol. 29, Iss. 7, pp. 683-697
Closed Access | Times Cited: 22
Recent advances in recurrent hepatocellular carcinoma therapy
Yuxue Gao, Qi-Qi Ning, Pengxiang Yang, et al.
World Journal of Hepatology (2023) Vol. 15, Iss. 4, pp. 460-476
Open Access | Times Cited: 17
Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation
Filippo Pelizzaro, Martina Gambato, Enrico Gringeri, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4882-4882
Open Access | Times Cited: 32
Immunotherapy Use Prior to Liver Transplant in Patients with Hepatocellular Carcinoma
Stephanie Woo, Alexandra V. Kimchy, Lynette M. Sequeira, et al.
Current Oncology (2022) Vol. 29, Iss. 12, pp. 9813-9825
Open Access | Times Cited: 20
Main factors influencing long-term outcomes of liver transplantation in 2022
Elisa Fuochi, Lorenzo Anastasio, Erica Nicola Lynch, et al.
World Journal of Hepatology (2023) Vol. 15, Iss. 3, pp. 321-352
Open Access | Times Cited: 13
When immunotherapy meets liver transplantation for hepatocellular carcinoma: A bumpy but promising road
Yufeng Gu, Shengjun Xu, Zhengxin Wang, et al.
Chinese Journal of Cancer Research (2023) Vol. 35, Iss. 2, pp. 92-107
Open Access | Times Cited: 11
Downstaging of Hepatocellular Carcinoma Before Liver Transplantation: Current Advances in Selection Criteria and Therapeutic Options
Li Pang, Lei-Bo Xu, Wenrui Wu
Transplantation Proceedings (2024) Vol. 56, Iss. 6, pp. 1396-1405
Closed Access | Times Cited: 4
Personalized translational medicine: Investigating YKL-40 as early biomarker for clinical risk stratification in hepatocellular carcinoma recurrence post-liver transplantation
Ileana Lulić, Dinka Lulić, Jadranka Pavičić Šarić, et al.
World Journal of Transplantation (2025) Vol. 15, Iss. 2
Closed Access
Recent Strategies to Attenuate Hepatocellular Carcinoma Recurrence After Liver Transplantation: A Narrative Review
Yutaka Endo, Yuki Bekki, Roberto Hernandez‐Alejandro, et al.
Cancers (2025) Vol. 17, Iss. 10, pp. 1650-1650
Open Access
The Role of mTOR Inhibitors after Liver Transplantation for Hepatocellular Carcinoma
Letizia Todeschini, Luca Cristin, Alessandro Martinino, et al.
Current Oncology (2023) Vol. 30, Iss. 6, pp. 5574-5592
Open Access | Times Cited: 9
Proper assessment and prognostication of patients with hepatocellular carcinoma
Edoardo G. Giannini
Clinical Liver Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Progression of AFP SCORE is a Preoperative Predictive Factor of Microvascular Invasion in Selected Patients Meeting Liver Transplantation Criteria for Hepatocellular Carcinoma
Astrid Herrero, Lucile Boivineau, Gianluca Cassese, et al.
Transplant International (2022) Vol. 35
Open Access | Times Cited: 14
Incremental value of radiomics-based heterogeneity to the existing risk criteria in predicting recurrence of hepatocellular carcinoma after liver transplantation
Pei Nie, Juntao Zhang, Wenjie Miao, et al.
European Radiology (2023) Vol. 33, Iss. 9, pp. 6608-6618
Closed Access | Times Cited: 7
Everolimus Personalized Therapy: Second Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology
Satohiro Masuda, F. Lemaı̂tre, Markus J. Barten, et al.
Therapeutic Drug Monitoring (2024)
Closed Access | Times Cited: 2
Predictors of post-recurrence survival in hepatocellular carcinoma patients following liver transplantation: Systematic review and meta-analysis
Abdulahad Abdulrab Mohammed Al‐Ameri, Xiaobo Yu, Shusen Zheng
Transplantation Reviews (2021) Vol. 36, Iss. 1, pp. 100676-100676
Closed Access | Times Cited: 14
Hepatocellular Carcinoma: The Role of Immunotherapy and Transplantation in the Era of Transplant Oncology
Saad Alghamdi, Waleed Al-hamoudi
Cancers (2023) Vol. 15, Iss. 21, pp. 5115-5115
Open Access | Times Cited: 5
Role of preoperative prediction of microvascular invasion in hepatocellular carcinoma based on the texture of FDG PET image: A comparison of quantitative metabolic parameters and MRI
Huazheng Shi, Ying Duan, Jie Shi, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 8
Plasma MicroRNA Panel Predicts Early Tumor Recurrence in Patients with Hepatocellular Carcinoma after Liver Transplantation
Ao Huang, De‐Zhen Guo, Yupeng Wang, et al.
Journal of Cancer (2021) Vol. 12, Iss. 23, pp. 7190-7200
Open Access | Times Cited: 10
Seven oxidative stress-related genes predict the prognosis of hepatocellular carcinoma
Chen Miao, Xiaodong He, Gang Chen, et al.
Aging (2023) Vol. 15, Iss. 24, pp. 15050-15063
Open Access | Times Cited: 3
Liver transplantation for alcohol-associated hepatitis
Claire Durkin, Therese Bittermann
Current Opinion in Organ Transplantation (2022)
Open Access | Times Cited: 5
Scoring systems for the management of oncological hepato-pancreato-biliary patients
Alexander W. Coombs, Chloe Jordan, S Hussain, et al.
Annals of Hepato-Biliary-Pancreatic Surgery (2022) Vol. 26, Iss. 1, pp. 17-30
Open Access | Times Cited: 4
Performance of eight predictive models for hepatocellular carcinoma recurrence after liver transplantation: A comparative study
Ajácio Brandão, Santiago Rodríguez, Cláudio Augusto Marroni, et al.
Annals of Hepatology (2023) Vol. 29, Iss. 2, pp. 101184-101184
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top